Recent developments in structure-based drug design

Journal of Molecular Medicine

Volumn 78, Issue 5, 2000, Pages 269-281

  Klebe, Gerhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Comparative molecular field analysis; Computer methods; Drug design; Three dimensional QSAR; X ray crystallography

Indexed keywords

10 PROPARGYL 5,8 DIDEAZAFOLIC ACID; GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; THROMBIN; THROMBIN INHIBITOR; THYMIDYLATE SYNTHASE; THYMIDYLATE SYNTHASE INHIBITOR;

BINDING AFFINITY; COMPUTER SYSTEM; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR RECOGNITION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SHIGELLA DYSENTERIAE; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 0033915678     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000084     Document Type: Review

References (54)

1. 1. Böhm H J, Klebe G (1996) What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs? Angew Chem Int Ed Engl 35:2588-2614
2. 2. Babine RE, Bender SL (1997) Molecular recognition of protein-ligand complexes: applications to drug design. Chem Rev 97:1359-1472
3. 3. Müller K (1995) De novo design, vol 3. In: Anderson PS, Kenyon GL, Marshall GR (eds) Persp drug discovery and design. ESCOM, Leiden
4. 4. Kubinyi H (1998) Structure-based design of enzyme inhibitors and receptor ligands. Curr Opin Drug Discov Dev 1:4-15
5. 5. Van Drie JH, Lajiness MS (1998) Approaches to virtual library design. Drug Discov Today 3:274-283
6. 6. Walters WP, Stahl MT, Murcko MA (1998) Virtual screening -an overview. Drug Discov Today 3:160-178
7. 7. Böhm HJ, Klebe G, Kubinyi H (1996) Wirkstoffdesign. Spektrum, Heidelberg
8. 8. Hol WGJ (1986) Protein crystallography and computer graphics - toward rational drug design. Angew Chem Int Ed Engl 25:767-778
9. 9. Walkinshaw MD (1992) Protein targets for structure-based drug design. Med Res Rev 12:317-372
10. 10. Bedell CR, Goodford PJ, Norrington FE (1976) Compounds designed to fit a site of known structure in human hemoglobin. Br J Pharmacol 57:201-209
11. 11. Goodford P (1984) Drug design by the method of receptor fit. J Med Chem 27:557-564
12. 12. Cushman DW, Cheung HS, Sabo EF, Ondetti MA (1977) Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16:5484-5491
13. 13. Lipsbomb WN, Hartsuch JA, Reehe GN, Quiocho FA, Bethge PH, Ludwig ML, Steitz TA, Muirhead H, Coppola JC (1968) The structure of carboxypeptidase A. VII. The 2 Å resolution studies of the enzyme and of its complex with glycyltyrosine, and mechanistic deductions. Brookh Symp Biol 1:24-90
14. 14. Navia MA, Murcko MA (1992) Use of structural information in drug design. Curr Opin Struct Biol 2:202-210
15. 15. West ML, Fairlie DP (1995) A test for drug-design methodologies. Trends Pharmacol Sci 16:67-74
16. 16. Lam PYS, Jadhav PK, Eyermann CJ, et al (1994) Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science 263:380-384
17. 17. Allen FA, Kennard O, Taylor R (1983) Systematic analysis of structural data as a research technique in organic chemistry. Accounts Chem Res 16:146-153
18. 18. Okada N, Nishimura S (1979) Isolation and characterization of a guanine insertion enzyme, a specific tRNA transglycosylase, from Escherichia coli. J Biol Chem 254:3061-3066
19. 19. Durand JM, Okada N, Tobe T, Watarai M, Fukuda I, Suzuki T, Nakata N, Komatsu K, Yoshikawa M, Sasakawa C (1994) VacC, a virulence-associated chromosomal locus of Shigella flexneri, is homologous to tgt, a gene encoding tRNA-guanine transglycosylase (Tgt) of Escherichia coli K-12. J Bacteriol 176:4627-4634
20. 20. Persson BC (1993) Modification of tRNA as a regulatory device. Mol Microbiol 8:1011-1016
21. 21. Rohde JE (1984) Selective primary health care: strategies for control of disease in the developing world. XV. Acute diarrhea. Brookh Dis 6:840
22. 22. Romier C, Reuter K, Suck D, Ficner R (1996) Crystal structure of tRNA-guanine transglycosylase from Zymononas mobilis: RNA modification by base exchange. EMBO J 15:2850-2857
23. 23. Böhm HJ (1992) The computer program Ludi: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6:61-78
24. 24. Böhm HJ (1992) Ludi: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput Aided Mol Des 6:593-606
25. 25. Klebe G (1994) The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands. J Mol Biol 237:212-235
26. 26. Majeux N, Scarsi M, Apostolakis J, Erhardt C, Caflish A (1999) Exhaustive docking of molecular fragments on protein binding sites with electrostatic solvation. Proteins Struct Funct Genetics 27:88-105
27. 27. Zhou X, Sun Y, Kuntz ID (1999) Inclusion of solvation in ligand binding free energy calculations using the generalized-Born model. J Am Chem Soc 121:8033-8043
28. 28. Böhm HJ (1994) The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput Aided Mol Des 8:243-256
29. 29. Mügge I, Martin YC (1999) A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem 42:791-804
30. 30. Mitchell JBO, Laskowski RA, Alex A, Thornton JM (1999) BLEEP-potential of mean force describing protein-ligand interactions. I. Generating potential. J Comp Chem 20:1156-1176
31. 31. Mitchell JBO, Laskowski RA, Alex A, Forster MJ, Thornton JM (1999) BLEEP-potential of mean force describing protein-ligand interactions. II. Calculation of binding energies and comparison with experimental data. J Comp Chem 20:1177-1185
32. 32. Gohlke H, Hendlich M, Klebe G (2000) Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol 295:337-356
33. 33. Reference deleted
34. 34. Montfort WR, Perry KM, Fauman EB, Finer-Moore JS, Maley GF, Hardy F, Marley F, Stroud RM (1990) Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding UMP and anti-folate. Biochemistry 29:6964-6977
35. 35. Reich SH, Fuhry MA, Nguyen D, et al (1992) Design and synthesis of novel 6,7-imidazotetrahydroquinoline inhibitors of thymidylate synthase using iterative protein crystal structure analysis. J Med Chem 35:847-858
36. 36. Reich SH, Webber SE (1993) Structure-based drug design (SBDD): every structure tells a story. Perspect Drug Discov Des 1:371-390
37. 37. Webber SE, Bleckman TM, Attard J, et al (1993) Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones. J Med Chem 36:733-746
38. 38. Jones TR, Varney MD, Webber SE, et al (1996) Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase. J Med Chem 39:904-917
39. 39. Goodford P (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28:849-857
40. 40. Davie EW, Fujikawa K, Kisiel W (1991) The coagulation cascade: initiation, maintenance and regulation. Biochemistry 30:10363-10370
41. 41. Obst U, Banner DW Weber L, Diederich F (1997) Molecular recoginiton at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structure of two thrombin-inhibitor complexes. Chem Biol 4:287-295
42. 42. Obst U, Gramlich V, Diederich F, Weber L, Banner DW (1995) Design of novel, nonpeptidic thrombin inhibitors and structure of a thrombin-inhibitor complex. Angew Chem Int Ed Engl 34:1739-1742
43. 43. Bode W, Brandstetter H, Mather T, Stubbs MT (1997) Comparative analysis of haemostatic proteinases: structural aspects of thrombin, factor Xa, factor IXa and protein C. Thromb Haemost 78 501:511
44. 44. Stubbs MT, Huber R, Bode W (1995) Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin. FEBS Lett 375:103-107
45. 45. Renatus M, Bode W, Huber R, Stürzebecher J, Stubbs MT (1998) Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: Implications for the inhibition od factor Xa, tPA and urokinase. J Med Chem 41 5445:5456
46. 46. Stubbs MT (1996) Structural aspects of factor Xa inhibition. Curr Pharm Des 2:543-552
47. 47. Cramer RD III, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959-5967
48. 48. Cramer RD III, DePriest SA, Patterson DE, Hecht P (1993) The development of comparative molecular filed analysis. In: Kubinyi H (ed) 3D QSAR. ESCOM, Leiden, pp 583-618
49. 49. Klebe G (1998) Comparative molecular similarity indices analysis: CoMSIA. Perspect Drug Discov Des 12:87-104
50. 50. Böhm M, Stürzebecher J, Klebe G (1999) Three-dimensional quantitative structure-activity relationship analysis using comparative molecular field analysis and comparative similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. J Med Chem 42:458-477
51. 51. Turk D, Stürzebecher J, Bode W (1991) Geometry of binding of the Nα-tosylated piperidides of m-amidino-, p-amidino-and p-guanidino phenylalanine to thrombin and trypsin. X-ray crystal structures of their trypsin complexes and modeling of their thrombin complexes. FEBS Lett 287:133-138
52. 52. Brandstetter H, Turk D, Höffken HW, Grosse D, Stürzebecher J, Martin PD, Edwards BF, Bode W (1992) Refined 2.3 Å X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. J Mol Biol 226:10851099
53. 53. Padmanabhan K, Padmanabhan KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT, Cardin AD, Kisiel W (1993) Structure of human des (1-45) factor Xa at 2.2 Å resolution. J Mol Biol 232:947-966
54. 54. Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130-4146